Paul Tudor Jones’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.47M Buy
+128,796
New +$3.46M 0.01% 1361
2025
Q4
Sell
-387,493
Closed -$16.6M 3710
2025
Q3
$22M Buy
387,493
+36,195
+10% +$1.85M 0.04% 397
2025
Q2
$17.5M Sell
351,298
-31,270
-8% -$1.41M 0.04% 386
2025
Q1
$11.3M Buy
382,568
+229,551
+150% +$8.53M 0.04% 413
2024
Q4
$3.7M Buy
+153,017
New +$3.79M 0.01% 861
2024
Q3
Sell
-970,659
Closed -$17.4M 2875
2024
Q2
$19.6M Buy
970,659
+480,841
+98% +$8M 0.1% 172
2024
Q1
$7.58M Buy
+489,818
New +$5.52M 0.05% 450
2023
Q3
Sell
-467,532
Closed -$4.39M 2521
2023
Q2
$4.39M Buy
467,532
+78,713
+20% +$780K 0.05% 484
2023
Q1
$3.86M Buy
+388,819
New +$3.41M 0.06% 483
2022
Q4
Sell
-98,462
Closed -$549K 2578
2022
Q3
$549K Buy
+98,462
New +$593K 0.01% 1326
2021
Q3
Sell
-48,379
Closed -$527K 2598
2021
Q2
$527K Buy
+48,379
New +$575K 0.01% 1134

Other funds holding HIMS

Paul Tudor Jones's HIMS Position: Q2 2026 in Review

Paul Tudor Jones opened a new position in Hims & Hers Health (HIMS) in Q2 2026: 128,796 shares worth $4.47M. The stake represents 0.01% of the portfolio and ranks #1361 among its holdings. This is a return to the name: Paul Tudor Jones previously reported a position in HIMS as recently as Q3 2025.

Paul Tudor Jones first reported a position in HIMS in Q2 2021 and has held it in 11 quarters since. The position peaked at $22M in Q3 2025. 504 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • Paul Tudor Jones held 128,796 shares of Hims & Hers Health worth $4.47M as of Q2 2026.
  • Hims & Hers Health was a new Paul Tudor Jones position in Q2 2026.
  • Hims & Hers Health made up 0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #1361 holding.
  • Paul Tudor Jones first reported a position in Hims & Hers Health in Q2 2021 and has held it in 11 quarters since.
  • Paul Tudor Jones's Hims & Hers Health position peaked at $22M in Q3 2025.
  • 504 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.